A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.
For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.
University of Chicago Cancer Research Center, Chicago, Illinois, United States
Rush University Medical Center, Chicago, Illinois, United States
University of Illinois Medical Center, Chicago, Illinois, United States
Children's Hospital Central California, Madera, California, United States
Maine Children's Cancer Program, Scarborough, Maine, United States
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States
Pinderfields General Hospital, Wakefield, Scotland, United Kingdom
Aintree University Hospital, Liverpool, England, United Kingdom
City Hospital - Birmingham, West Bromwich, England, United Kingdom
Ospedale San Filippo Neri, Rome, Italy
Universita Degli Studi di Bari Policlinico, Bari, Italy
Ospedale Oncologico A. Businco, Cagliari, Italy
Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands
Ostra Sjukhuset, Gothenburg, Sweden
Centre Hospitalier Regional de Purpan, Toulouse, France
Rikshospitalet University Hospital, Oslo, Norway
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
St. Anna Children's Hospital, Vienna, Austria
Universitair Ziekenhuis Gent, Ghent, Belgium
Rikshospitalet University Hospital, Oslo, Norway
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Centre Hospitalier Regional de Purpan, Toulouse, France
Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin, Germany
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany
Universitaetsklinikum Essen, Essen, Germany
AZ Sint-Jan, Brugge, Belgium
Ospedale Civile Alessandria, Alessandria, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.